Genetic Signatures Ltd

ASX:GSS (Australia)  
A$ 0.52 (+1.98%) Nov 29
At Loss
P/B:
1.72
Market Cap:
A$ 73.85M ($ 48.84M)
Enterprise V:
A$ 47.01M ($ 31.09M)
Volume:
37.13K
Avg Vol (2M):
62.80K
Warning! GuruFocus detected 2 Severe warning signs with GSS. Try a 7-Day Free Trial to check it out.
Volume:
37.13K
Market Cap A$:
73.85M
Market Cap $:
48.84M
At Loss
Avg Vol (2M):
62.80K
Enterprise Value A$:
47.01M
Enterprise Value $:
31.09M
PB Ratio:
1.72
Alerts Website Sources Stock PDF
Dataset
Financial Download Manual of Stocksâ„¢

Business Description

Genetic Signatures Ltd

ISIN : AU000000GSS4
https://www.geneticsignatures.com
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Compare
Compare
ASX:MAPASX:IIQASX:RHYASX:LDXASX:CTEASX:BDXASX:GTGASX:IBXTMODHRSHSE:603259IDXXIQVAXSWX:LONNMTDICLRILMNLHDGX
Traded in other countries / regions
GSS.Australia
IPO Date
2015-03-31
Description
Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.

Financial Strength

9/10
Name Current Vs Industry Vs History
Cash-To-Debt 8174.5
Equity-to-Asset 0.87
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.74
Distress
Grey
Safe
Beneish M-Score -1.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

6/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 18.7
3-Year EBITDA Growth Rate -113
3-Year EPS without NRI Growth Rate -83
3-Year FCF Growth Rate -15.4
3-Year Book Growth Rate -2.4

Momentum Rank

1/10
Name Current Vs Industry Vs History
5-Day RSI 70.5
9-Day RSI 61.37
14-Day RSI 57
6-1 Month Momentum % -19.35
12-1 Month Momentum % -44.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.99
Quick Ratio 4.55
Cash Ratio 2.69
Days Inventory 445.87
Days Sales Outstanding 62.91
Days Payable 158.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2
Shareholder Yield % 0.17

Profitability Rank

3/10
Name Current Vs Industry Vs History
Gross Margin % 62.57
Operating Margin % -69.04
Net Margin % -65.79
FCF Margin % -96.18
ROE % -28.72
ROA % -25.98
ROIC % -62.73
ROC (Joel Greenblatt) % -78.38
ROCE % -28.67
Years of Profitability over Past 10-Year 2

GF Value Rank

8/10
Name Current Vs Industry Vs History
PS Ratio 3.46
PB Ratio 1.72
Price-to-Tangible-Book 1.98
EV-to-EBIT -3.34
EV-to-EBITDA -3.74
EV-to-Revenue 2.21
EV-to-Forward-Revenue 5.72
EV-to-FCF -2.15
Price-to-Net-Current-Asset-Value 2.45
Price-to-Net-Cash 7.36
Earnings Yield (Greenblatt) % -29.91
FCF Yield % -27.82

Financials

ASX:GSS's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Genetic Signatures Ltd Executives

Details

GF Value: A$1.02

ASX:GSS

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 21.36
EPS (TTM) (A$) -0.098
Beta 0.75
Volatility % 57.17
14-Day RSI 57
14-Day ATR (A$) 0.015964
20-Day SMA (A$) 0.48275
12-1 Month Momentum % -44.44
52-Week Range (A$) 0.435 - 0.995
Shares Outstanding (Mil) 143.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genetic Signatures Ltd Filings

Filing Date Document Date Form
No Filing Data

Genetic Signatures Ltd Stock Events

Event Date Price(A$)
No Event Data

Genetic Signatures Ltd Frequently Asked Questions

What is Genetic Signatures Ltd(ASX:GSS)'s stock price today?
The current price of ASX:GSS is A$0.52. The 52 week high of ASX:GSS is A$1.00 and 52 week low is A$0.44.
When is next earnings date of Genetic Signatures Ltd(ASX:GSS)?
The next earnings date of Genetic Signatures Ltd(ASX:GSS) is .
Does Genetic Signatures Ltd(ASX:GSS) pay dividends? If so, how much?
Genetic Signatures Ltd(ASX:GSS) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2023 GuruFocus.com, LLC. All Rights Reserved.